Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6945 stock hub

TPEX/6945 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6945is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14.7B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6945

In the news

Latest news · TPEX/6945

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-30.7

P25 -16.2P50 0.3P75 9.8

ROIC-18.9

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6945 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

145

Groups with data

Currency

TWD

Showing 145 of 145 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees Change	11%
Employees Change Percent	42.31
Enterprise value	TWD 13.6B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0006945009
Last refreshed	2026-05-10
Market cap	TWD 14.7B
Price	TWD 172
Price currency	TWD
Sector	Healthcare
Sic	2836
Symbol	tpex/6945
Website	https://www.apbioinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.02%
EV Earnings	-30.59x
EV/FCF	-36.08x
FCF yield	-2.56%
P/B ratio	11.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	TWD -444.8M
Net Income Growth Years	0%
ROA	-18.45
Roa5y	-20.45
ROCE	-34.46
ROE	-30.74
Roe5y	-33.6
ROIC	-18.86

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	244.29%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	TWD 1.4B
Cash	TWD 1.2B
Current Assets	TWD 1.2B
Current Liabilities	TWD 40.8M
Debt	TWD 59.5M
Debt Equity	TWD 0.05
Debt FCF	TWD -0.16
Equity	TWD 1.3B
Interest Coverage	-320.5
Liabilities	TWD 94.2M
Long Term Assets	TWD 143.7M
Long Term Liabilities	TWD 53.4M
Net Cash	TWD 1.1B
Net Cash By Market Cap	TWD 7.55
Net Cash Growth	-24.43%
Net Debt Equity	TWD -0.87
Tangible Book Value	TWD 1.3B
Tangible Book Value Per Share	TWD 14.82
WACC	2.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	29.94
Net Working Capital	TWD 21.6M
Quick ratio	29.73
Working Capital	TWD 1.2B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	244%
200-day SMA	143.7
50-day SMA	187.5
50-day SMA vs 200-day SMA	50over200
All Time High	236
All Time High Change	-27.12%
All Time High Date	2026-03-25
All Time Low	36.3
All Time Low Change	373.83%
All Time Low Date	2025-04-09
ATR	12.32
Beta	-0.3
Beta1y	-0.36
Beta2y	0.42
Ch YTD	-4.44
High	175
High52	236
High52 Date	2026-03-25
High52ch	-27.12%
Low	170
Low52	49.2
Low52 Date	2025-05-08
Low52ch	250.31%
Ma50ch	-8.28%
Price vs 200-day SMA	19.69%
RSI	40.19
RSI Monthly	69.71
RSI Weekly	55.43
Sharpe ratio	1.88x
Sortino ratio	4.85
Total Return	-13.06%
Tr YTD	-4.44
Tr1m	-14.64%
Tr1w	2.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -456.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	42,272,622%
Net Borrowing	-11,397,000
Shares Insiders	5.87%
Shares Institutions	5.26%
Shares Out	85,573,410
Shares Qo Q	0.18%
Shares Yo Y	13.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -452.3M
Average Volume	628,834x
Bv Per Share	14.85
CAPEX	TWD -25M
Ch1m	-14.64
Ch1w	2.08
Ch1y	244
Ch6m	46.38
Change	-0.86%
Change From Open	-1.71
Close	173.5
Days Gap	0.86
Depreciation Amortization	13,276,000
Dollar Volume	31,602,420
Earnings Date	2026-05-12
EBIT	TWD -456.4M
EBITDA	TWD -443.1M
EPS	TWD -5.23
F Score	1
FCF	TWD -377.1M
FCF EV Yield	-2.77x
FCF Per Share	TWD -4.41
Financing CF	4,512,000
Fiscal Year End	December
Founded	2,013
Investing CF	-125,254,000
Is Primary Listing	1
Last Earnings Date	2025-11-12
Last Report Date	2025-12-31
Ma150	156.6
Ma150ch	9.82%
Ma20	187.3
Ma20ch	-8.18%
Net CF	-470,750,000
Next Earnings Date	2026-05-12
Open	175
Position In Range	40
Ppne	108,942,000
Price Date	2026-05-08
Ptbv Ratio	11.61
Relative Volume	0.29x
Share Based Comp	75,131,000
Tr6m	46.38%
Volume	183,735

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6945 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6945 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6945?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.3%

Share of float held by funds and institutions

Insider ownership

+5.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+13.1%

Negative means the company is buying back shares.

Technical

TPEX/6945 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.2

Neutral momentum band

Price vs 200-day MA

+19.7%

50/200-day relationship not available

Beta (5Y)

-0.30

Less volatile than the market

Sharpe ratio

1.88

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6945

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6945 stock rating?

tpex/6945 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6945 analysis?

The full report lives at /stocks/tpex/6945/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6945?

The latest report frames tpex/6945 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6945 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.